Mannie, Mark D.2019-10-302019-10-302017-05-10http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=10363306.PN.&OS=PN/10363306&RS=PN/10363306US Pat# 10363306http://hdl.handle.net/10342/7520Inventors: Mannie; Mark D. (Greenville, NC) Full text available at: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=10363306.PN.&OS=PN/10363306&RS=PN/10363306The present invention provides methods of regulating an immunological disorder comprising administering to a subject an effective amount of (i) an autoimmune antigen in conjunction with (ii) an anti-inflammatory cytokine. Compositions including the same are also provided.en-USImmune disorderCytokineMultiple sclerosisGene therapyPatent